The three subtypes of beta adrenergic receptors, β1-AR, β2-AR, and β3-AR are present at many sites of tumor growth and metastasis including pancreatic [47], lung [48], breast cancer [49], melanoma [50], prostate cancer [51], and neuroblastoma [52]. This evidence concerns the gene ADRB2 and neoplasm.